This announcement is a separate document:
未名医药：董事会关于2023年度财务报告非标准审计意见涉及事项的专项说明
Shandong Sinobioway Biomedicine: Special note by the board of directors on matters relating to non-standard audit opinions on the 2023 financial report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.